Abstract
Summary: Background: Intravenous ketorolac is commonly administered to children for the control of postoperative pain. An effect siteEC50for analgesia of 0.37 mg.L−1is described in adults.Aims: The aim of this study was to review age‐ and weight‐related effects on ketorolac pharmacokinetic parameters in children and current dosing schedules.Methods: Pooled intravenous ketorolac (0.5 mg.kg−1) concentration‐time data in children aged 2 months to 16 years were analyzed using nonlinear mixed‐effects models. Allometry was used to scale to a 70 kg person.Results: There were 64 children aged 2 months to 16 years (641 plasma concentrations) available for analysis. A two‐compartment mammillary model was used to describe pharmacokinetics. Clearance was 2.53 (CV45.9%) L.h−1.70 kg−1and intercompartment clearance was 4.43 (CV95.6%) L.h−1.70 kg−1. Both central (V1) and peripheral (V2) volumes of distribution decreased with age over the first few years of postnatal life to reach V1 6.89 (CV30.3%) L.70 kg−1and V2 5.53 (CV47.6%) L.70 kg−1.Conclusion: Clearance, expressed as L.h−1.kg−1, decreased with age from infancy. A dosing regimen of 0.5 mg.kg−1every 6 hours maintains a trough concentration larger than 0.37 mg.L−1in children 9 months to 16 years of age. This dosing regimen is consistent with current recommendations.
Funding Information
  • institutional resources

This publication has 37 references indexed in Scilit: